title: Therapeutic options in Charles Bonnet syndrome.
abstract: The term 'Charles Bonnet syndrome' refers to visual pseudohallucinations occurring especially in elderly people with reduced visual acuity. Despite numerous case reports, few successful methods of treatment have been described. Therapies with classical neuroleptics, antidepressants or benzodiazepines have generally been found to be unpromising. Only with carbamazepine treatment has improvement been observed in a few cases. In the three cases reported here, we successfully treated the condition with the atypical neuroleptic melperone.
authors.affiliation: Department of Psychiatry and Psychotherapy, University of Tübingen, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Batra
authors.forename: M
authors.initials: M
authors.lastname: Bartels
authors.forename: H
authors.initials: H
authors.lastname: Wormstall
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002090:Butyrophenones / Q000627:therapeutic use*; D005260:Female; D005852:Geriatric Psychiatry / Q000379:methods*; D006212:Hallucinations / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010469:Perceptual Distortion / Q000187:drug effects*; D013577:Syndrome; D014786:Vision Disorders / Q000150:complications*
chemical_list: D014150:Antipsychotic Agents; D002090:Butyrophenones; C008522:metylperon